
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Recent Advances in Fungal Infections: From Lung Ecology to Therapeutic Strategies With a Focus on Aspergillus spp.
Fabio Palmieri, Angela Koutsokera, Eric Bernasconi, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 29
Fabio Palmieri, Angela Koutsokera, Eric Bernasconi, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 29
Showing 1-25 of 29 citing articles:
Interplay of Cytokines and Chemokines in Aspergillosis
Jata Shankar, Raman Thakur, Karl V. Clemons, et al.
Journal of Fungi (2024) Vol. 10, Iss. 4, pp. 251-251
Open Access | Times Cited: 15
Jata Shankar, Raman Thakur, Karl V. Clemons, et al.
Journal of Fungi (2024) Vol. 10, Iss. 4, pp. 251-251
Open Access | Times Cited: 15
Multi-therapeutic potential of flavonoids as an essential component in nutraceuticals for the treatment and management of human diseases
Stanley I.R. Okoduwa, Ibrahim Abdulwaliyu, Bernard E. Igiri, et al.
Phytomedicine Plus (2024) Vol. 4, Iss. 2, pp. 100558-100558
Open Access | Times Cited: 13
Stanley I.R. Okoduwa, Ibrahim Abdulwaliyu, Bernard E. Igiri, et al.
Phytomedicine Plus (2024) Vol. 4, Iss. 2, pp. 100558-100558
Open Access | Times Cited: 13
The importance, benefits, and future of nanobiosensors for infectious diseases
Th. S. Dhahi, Alaa Kamal Yousif Dafhalla, Sawsan Ali Saad, et al.
Biotechnology and Applied Biochemistry (2024) Vol. 71, Iss. 2, pp. 429-445
Closed Access | Times Cited: 5
Th. S. Dhahi, Alaa Kamal Yousif Dafhalla, Sawsan Ali Saad, et al.
Biotechnology and Applied Biochemistry (2024) Vol. 71, Iss. 2, pp. 429-445
Closed Access | Times Cited: 5
How Does Airway Surface Liquid Composition Vary in Different Pulmonary Diseases, and How Can We Use This Knowledge to Model Microbial Infections?
Dean Walsh, Jennifer Bevan, Freya Harrison
Microorganisms (2024) Vol. 12, Iss. 4, pp. 732-732
Open Access | Times Cited: 5
Dean Walsh, Jennifer Bevan, Freya Harrison
Microorganisms (2024) Vol. 12, Iss. 4, pp. 732-732
Open Access | Times Cited: 5
Synergistic and potential antifungal properties of tailored, one pot multicomponent monoterpenes co-delivered with fluconazole encapsulated nanostructure lipid carrier
Ibrahim Taha Radwan, Ibrahim M. El‐Sherbiny, Nadia H. Metwally
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Ibrahim Taha Radwan, Ibrahim M. El‐Sherbiny, Nadia H. Metwally
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Clinical Aspergillus Signatures in COPD and Bronchiectasis
Pei Yee Tiew, Kai Xian Thng, Sanjay H. Chotirmall
Journal of Fungi (2022) Vol. 8, Iss. 5, pp. 480-480
Open Access | Times Cited: 20
Pei Yee Tiew, Kai Xian Thng, Sanjay H. Chotirmall
Journal of Fungi (2022) Vol. 8, Iss. 5, pp. 480-480
Open Access | Times Cited: 20
Diagnostic Approach to Pneumonia in Immunocompromised Hosts
Nadir Ullah, Ludovica Fusco, Luigi Ametrano, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 389-389
Open Access
Nadir Ullah, Ludovica Fusco, Luigi Ametrano, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 389-389
Open Access
Progress Advances in Etiological Diagnosis of Severe Community-Acquired Pneumonia
智岭 赵
Advances in Clinical Medicine (2025) Vol. 15, Iss. 01, pp. 2115-2122
Closed Access
智岭 赵
Advances in Clinical Medicine (2025) Vol. 15, Iss. 01, pp. 2115-2122
Closed Access
Clinical aspects and recent advances in fungal diseases impacting human health
Livio Pagano, Óscar Fernández
Journal of Antimicrobial Chemotherapy (2025) Vol. 80, Iss. Supplement_1, pp. i2-i8
Open Access
Livio Pagano, Óscar Fernández
Journal of Antimicrobial Chemotherapy (2025) Vol. 80, Iss. Supplement_1, pp. i2-i8
Open Access
Synthesis of New Azoles For the Treatment of Resistant Infections Caused By Who Critical Priority Fungi: Therapeutic Challenges and Innovations in The Fight Against Them
Amanda Vieira de Barros, José Henrique Serafim Batista da Silva, Isabela Ribeiro, et al.
Revista de Gestão Social e Ambiental (2025) Vol. 19, Iss. 3, pp. e011670-e011670
Closed Access
Amanda Vieira de Barros, José Henrique Serafim Batista da Silva, Isabela Ribeiro, et al.
Revista de Gestão Social e Ambiental (2025) Vol. 19, Iss. 3, pp. e011670-e011670
Closed Access
Targeting DNA Topoisomerase II in Antifungal Chemotherapy
Kavya Kondaka, Iwona Gabriel
Molecules (2022) Vol. 27, Iss. 22, pp. 7768-7768
Open Access | Times Cited: 14
Kavya Kondaka, Iwona Gabriel
Molecules (2022) Vol. 27, Iss. 22, pp. 7768-7768
Open Access | Times Cited: 14
Phytochemical screening, antimicrobial and antioxidant properties of Douepia tortuosa Camb., a crucifer endemic to Pakistan
Irfan Ullah, Tahir Iqbal, Faizan Ullah, et al.
Pakistan Journal of Botany (2024) Vol. 56, Iss. 3
Open Access | Times Cited: 2
Irfan Ullah, Tahir Iqbal, Faizan Ullah, et al.
Pakistan Journal of Botany (2024) Vol. 56, Iss. 3
Open Access | Times Cited: 2
Nanomedicines for Pulmonary Drug Delivery: Overcoming Barriers in the Treatment of Respiratory Infections and Lung Cancer
Raquel Fernández-García, Ana Isabel Fraguas‐Sánchez
Pharmaceutics (2024) Vol. 16, Iss. 12, pp. 1584-1584
Open Access | Times Cited: 2
Raquel Fernández-García, Ana Isabel Fraguas‐Sánchez
Pharmaceutics (2024) Vol. 16, Iss. 12, pp. 1584-1584
Open Access | Times Cited: 2
Carbon Nanotube Hybrid Materials: Efficient and Pertinent Platforms for Antifungal Drug Delivery
Dilip Kumar Chandra, Rui L. Reis, Subhas C. Kundu, et al.
Advanced Materials Technologies (2023) Vol. 8, Iss. 23
Open Access | Times Cited: 5
Dilip Kumar Chandra, Rui L. Reis, Subhas C. Kundu, et al.
Advanced Materials Technologies (2023) Vol. 8, Iss. 23
Open Access | Times Cited: 5
Rethinking Aspergillosis in the Era of Microbiota and Mycobiota
Aleksandra Barać, Ankica Vujović, Jovan Perić, et al.
Mycopathologia (2024) Vol. 189, Iss. 4
Closed Access | Times Cited: 1
Aleksandra Barać, Ankica Vujović, Jovan Perić, et al.
Mycopathologia (2024) Vol. 189, Iss. 4
Closed Access | Times Cited: 1
Posaconazole nanocrystals dry powder inhalers for the local treatment of invasive pulmonary aspergillosis
Xuchun Li, Qing Wang, Jiewen Huang, et al.
International Journal of Pharmaceutics (2024) Vol. 668, pp. 124938-124938
Open Access | Times Cited: 1
Xuchun Li, Qing Wang, Jiewen Huang, et al.
International Journal of Pharmaceutics (2024) Vol. 668, pp. 124938-124938
Open Access | Times Cited: 1
Mortality and Clinical Outcomes of Aspergillus and COVID-19 Co-infection: A Retrospective Analysis
Juliana Cazzaniga, Nicole Koutras, Premalkumar Patel
Cureus (2023)
Open Access | Times Cited: 2
Juliana Cazzaniga, Nicole Koutras, Premalkumar Patel
Cureus (2023)
Open Access | Times Cited: 2
Antifungal activity of selected sea cucumber species from Tukuran, Zamboanga del Sur, Mindanao, Philippines using modified SPOTi assay
MARY GRACE EREGUERO, Mary Anne W. Cordero, Rodelyn Dalayap, et al.
Biodiversitas Journal of Biological Diversity (2022) Vol. 23, Iss. 11
Open Access | Times Cited: 3
MARY GRACE EREGUERO, Mary Anne W. Cordero, Rodelyn Dalayap, et al.
Biodiversitas Journal of Biological Diversity (2022) Vol. 23, Iss. 11
Open Access | Times Cited: 3
Unveiling the Masquerade: Pulmonary Mycosis Mimicking Pulmonary Malignancy- A Case Series
Haris Zia, M. D., Ene Andre, et al.
Journal of Infectious Diseases and Epidemiology (2024) Vol. 10, Iss. 5
Open Access
Haris Zia, M. D., Ene Andre, et al.
Journal of Infectious Diseases and Epidemiology (2024) Vol. 10, Iss. 5
Open Access
Haris Zia, Matthew Mccoy App, Andre Ene, et al.
Journal of Infectious Diseases and Epidemiology (2024) Vol. 10, Iss. 5
Open Access
Using RAPD Market for Detection Resistant Aspergillus Fumigatus to Some Antifungals
Israa Abdel Munem Yaseen, Humam Saadi Hussein, Mohammed Sami Farhan, et al.
Global Academic Journal of Pharmacy and Drug Research (2024) Vol. 6, Iss. 03, pp. 20-26
Open Access
Israa Abdel Munem Yaseen, Humam Saadi Hussein, Mohammed Sami Farhan, et al.
Global Academic Journal of Pharmacy and Drug Research (2024) Vol. 6, Iss. 03, pp. 20-26
Open Access
Molecular Method for the Detection of Resistance Aspergillus Fumigatus to Some Antifungal Agents
Israa Abdel Munem Yaseen, Humam Saadi Hussein, Mohammed Sami Farhan, et al.
Journal of Prevention Diagnosis and Management of Human Diseases (2024), Iss. 46, pp. 10-20
Open Access
Israa Abdel Munem Yaseen, Humam Saadi Hussein, Mohammed Sami Farhan, et al.
Journal of Prevention Diagnosis and Management of Human Diseases (2024), Iss. 46, pp. 10-20
Open Access
One-Step Soft Agar Enrichment and Isolation of Human Lung Bacteria Inhibiting the Germination of Aspergillus fumigatus Conidia
Fabio Palmieri, Jérémy Diserens, Manon Gresse, et al.
Microorganisms (2024) Vol. 12, Iss. 10, pp. 2025-2025
Open Access
Fabio Palmieri, Jérémy Diserens, Manon Gresse, et al.
Microorganisms (2024) Vol. 12, Iss. 10, pp. 2025-2025
Open Access
Bacteria and fungi of the lung: allies or enemies?
Enrico Garaci, Marilena Pariano, Emilia Nunzi, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Enrico Garaci, Marilena Pariano, Emilia Nunzi, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Recent Advances in the Management of Aspergillosis
Chhavi Gupta, Sajad Ahmad Dar
(2024), pp. 383-400
Closed Access
Chhavi Gupta, Sajad Ahmad Dar
(2024), pp. 383-400
Closed Access